Previous research has reported increased risk for psychosis among individuals who use cannabis during adolescence. We conducted a systematic review and meta-analysis to investigate the interaction between adolescent cannabis use and other factors in moderating risk for psychosis later in life.
Method
We searched four electronic databases in June 2020 for articles that assessed adolescent cannabis use, had psychosis as an outcome and analyzed for the association between adolescent cannabis use and psychosis. Analysis was done using random-effects meta-analysis and narrative synthesis.
Results
A total of 63 studies were included in the narrative review and 18 studies were included in the meta-analysis. Adolescent cannabis use was found to increase risk for psychosis (RR = 1.71 (95%CI, 1.47–2.00, p < 0.00001) and predict earlier onset of psychosis. The following factors moderate the relationship between cannabis use and the risk of psychosis: age of onset of cannabis use, frequent cannabis use, exposure to childhood trauma, concurrent use of other substances and genetic factors.
Conclusion
Adolescent cannabis use is associated with an increased risk for psychosis later in life. In addition, there are factors that moderate this relationship; therefore there is a need for research to assess the interaction between these factors, adolescent cannabis use and psychosis risk.
United Nations Office on Drug and Crime (UNODC). World drug report 2020: drug use and health consequences. United Nations Publication, Sales No. E20.XI.6. https://wdr.unodc.org. Accessed July 24, 2020.
2.
PeacockA, LeungJ, LarneyS, . Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–1926.
3.
DegenhardtL, CharlsonF, FerrariA, . The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.
4.
GreenB, YoungR, KavanaghD.Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry. 2005;187:306–313.
5.
CharlsonFJ, FerrariAJ, SantomauroDF, . Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44(6):1195–1203.
MaloneDT, HillMN, RubinoT.Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol. 2010;160(3):511–522.
8.
SchneiderM.Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol. 2008;13(2):253–263.
9.
KeshavanMS, GieddJ, LauJYF, LewisDA, PausT.Changes in the adolescent brain and the pathophysiology of psychotic disorders. Lancet Psychiatry. 2014;1(7):549–558.
10.
AshtonCH.Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–106.
11.
ChadwickB, MillerML, HurdYL.Cannabis use during adolescent development: susceptibility to psychiatric illness. Front Psychiatry. 2013;4:129.
12.
CasadioP, FernandesC, MurrayRM, Di FortiM.Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev. 2011;35(8):1779–1787.
13.
BagotKS, MilinR, KaminerY.Adolescent initiation of cannabis use and early-onset psychosis. Subst Abus. 2015;36(4):524–533.
14.
LorenzettiV, Alonso-LanaS, YoussefGJ, . Adolescent cannabis use: what is the evidence for functional brain alteration?Curr Pharm Des. 2016;22(42):6353–6365.
15.
MurrayRM, Di FortiM.Cannabis and psychosis: What degree of proof do we require?Biol Psychiatry. 2016;79(7):514–515.
16.
NielsenSM, ToftdahlNG, NordentoftM, HjorthøjC.Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study. Psychol Med. 2017;47(9):1668–1677.
Griffith‐LenderingMFH, WigmanJTW, van LeeuwenAP, . Cannabis use and vulnerability for psychosis in early adolescence—a TRAILS study. Addiction. 2013;108(4):733–740.
19.
GageSH, JonesHJ, BurgessS, . Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med. 2017;47(5):971–980.
20.
KsirC, HartCL.Cannabis and psychosis: a critical overview of the relationship. Curr Psychiatry Rep. 2016;18(2):1–11.
21.
PowerRA, VerweijKJH, ZuhairM, . Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014;19(11):1201–1204.
22.
GageSH, ZammitS, HickmanM.Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Med Rep. 2013;5(1):2–5.
23.
GomesFV, Rincón-CortésM, GraceAA.Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model. Neurosci Biobehav Rev. 2016;70:260–270.
24.
ParolaroD. Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences. Adicciones. 2010;22(3):185–190.
25.
ParakhP, BasuD.Cannabis and psychosis: have we found the missing links?Asian J Psychiatr. 2013;6(4):281–287.
26.
BagotKS, ChangA. Marijuana and psychosis: policy implications for treatment providers. J Am Acad Child Adolesc Psychiatry. 2018;57(8):613–614.
27.
WrightA, CatherC, GilmanJ, EvinsAE.The changing legal landscape of cannabis use and its role in youth-onset psychosis. Child Adolesc Psychiatr Clin N Am. 2020;29(1):145–156.
28.
MooreTHM, ZammitS, Lingford-HughesA, . Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319–328.
29.
SempleDM, McIntoshAM, LawrieSM.Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005;19(2):187–194.
30.
MarconiA, Di FortiM, LewisCM, MurrayRM, VassosE.Meta-Analysis of the association between the level of cannabis use and risk of psychosis. Schizophr Bull. 2016;42(5):1262–1269.
31.
HosseiniS, OremusM.The effect of age of initiation of cannabis use on psychosis, depression, and anxiety among youth under 25 years. Can J Psychiatry. 2019;64(5):304–312.
32.
van der SteurSJ, BatallaA, BossongMG.Factors moderating the association between cannabis use and psychosis risk: a systematic review. Brain Sci. 2020;10(2):97.
33.
LiberatiA, AltmanDG, TetzlaffJ, . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
34.
GarrardJ.2017. Health Sciences Literature Review Made Easy: The Matrix Method. Burlington, MA: Jones and Bartlett Learning.
35.
SterneJA, HernánMA, ReevesBC, . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:4–10.
36.
JonesJD, CalkinsME, ScottJC, BachEC, GurRE.Cannabis use, polysubstance use, and psychosis spectrum symptoms in a community-based sample of U.S. youth. J Adolesc Health. 2017;60(6):653–659.
37.
KostyDB, SeeleyJR, FarmerRF, StevensJJ, LewinsohnPM.Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Addiction. 2017;112(2):279–287.
38.
LevyS, WeitzmanER.Acute mental health symptoms in adolescent marijuana users. JAMA Pediatr. 2019;173(2):185–186.
39.
RyanJE, VelizP, McCabeSE, StoddardSA, BoydCJ.Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis. Schizophr Res. 2020;215:482–484.
40.
AutherAM, McLaughlinD, CarriónRE, NagachandranP, CorrellCU, CornblattBA.Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med. 2012;42(12):2485–2497.
41.
AutherAM, CadenheadKS, CarriónRE, . Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. Acta Psychiatr Scand. 2015;132(1):60–68.
42.
BechtoldJ, SimpsonT, WhiteHR, PardiniD.Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychol Addict Behav. 2015;29(3):552–563.
43.
BechtoldJ, HipwellA, LewisDA, LoeberR, PardiniD.Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms. Am J Psychiatry. 2016;173(8):781–789.
44.
DayNL, GoldschmidtL, DayR, LarkbyC, RichardsonGA.Prenatal marijuana exposure, age of marijuana initiation, and the development of psychotic symptoms in young adults. Psychol Med. 2015;45(8):1779–1787.
45.
HoustonJE, MurphyJ, AdamsonG, StringerM, ShevlinM.Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey. Schizophr Bull. 2008;34(3):580–585.
46.
KantrowitzJT, NolanKA, SenS, SimenAA, LachmanHM, BowersMBJ.Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians. Psychiatr Q. 2009;80(4):213–218.
47.
MackieCJ, Castellanos-RyanN, ConrodPJ.Developmental trajectories of psychotic-like experiences across adolescence: impact of victimization and substance use. Psychol Med. 2011;41(1):47–58.
48.
MackieCJ, O'Leary-BarrettM, Al-KhudhairyN, . Adolescent bullying, cannabis use and emerging psychotic experiences: A longitudinal general population study. Psychol Med. 2013;43(5):1033–1044.
49.
Di FortiM, SallisH, AllegriF, . Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull. 2014;40(6):1509–1517.
50.
Di FortiM, MarconiA, CarraE, . Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015;2(3):233–238.
51.
GageSH, HickmanM, HeronJ, . Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of parents and children. Psychol Med. 2014;44(16):3435–3444.
52.
ShakoorS, ZavosHMS, McGuireP, CardnoAG, FreemanD, RonaldA.Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors. Psychiatry Res. 2015;227(2–3):144–151.
53.
JonesHJ, GageSH, HeronJ, . Association of combined patterns of tobacco and cannabis use in adolescence with psychotic experiences. JAMA Psychiatry. 2018;75(3):240–246.
ParukS, BurnsJK, CaplanR.Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa. J Child Adolesc Ment Health. 2013;25(1):61–68.
56.
ParukS, JhazbhayK, SinghK, SartoriusB, BurnsJK.A comparative study of socio-demographic and substance use correlates in early-onset psychosis. Early Interv Psychiatry. 2018;12(3):339–347.
57.
Di FortiM, QuattroneD, FreemanTP, . The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry. 2019;6(5):427–436.
58.
QuattroneD, FerraroL, TripoliG, . Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study. Psychol Med. 2020:1–9. DOI:10.1017/S0033291720000082. Online ahead of print.
59.
LeadbeaterBJ, AmesME, Linden-CarmichaelAN.Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction. 2019;114(2):278–293.
60.
KoningsM, StefanisN, KuepperR, . Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol Med. 2012;42(1):149–159.
61.
BaezaI, GraellM, MorenoD, . Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009;113(2–3):129–137.
62.
Setien-SueroE, Martinez-GarciaO, de la FozV, . Age of onset of cannabis use and cognitive function in first-episode non-affective psychosis patients: outcome at three-year follow-up. Schizophr Res. 2018;201:159–166.
63.
AndréassonS, EngströmA, AllebeckP, RydbergU.Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. The Lancet. 1987;330(8574):1483–1486.
64.
Manrique-GarciaE, ZammitS, DalmanC, HemmingssonT, AndreassonS, AllebeckP.Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med. 2012;42(6):1321–1328.
65.
ZammitS, AllebeckP, AndreassonS, LundbergI, LewisG.Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325(7374):1199–1199.
66.
ZammitS, LewisG, DalmanC, AllebeckP.Examining interactions between risk factors for psychosis. Br J Psychiatry. 2010;197(3):207–211.
67.
BourqueJ, AfzaliMH, O'Leary-BarrettM, ConrodP.Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators. J Child Psychol Psychiatry. 2017;58(12):1360–1369.
68.
MustonenA, NiemeläS, NordströmT, MurrayGK, MäkiP, JääskeläinenE.Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis. Br J Pschiatry. 2018;212(4):227–233.
69.
ArseneaultL, CannonM, PoultonR, MurrayR, CaspiA, MoffittTE.Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374):1212–1213.
70.
FergussonDM, HorwoodLJ, Swain-CampbellNR.Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003;33(1):15–21.
71.
CaspiA, MoffittTE, CannonM, . Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117–1127.
72.
HenquetC, KrabbendamL, SpauwenJ, . Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330(7481):11.
73.
KuepperR, van OsJ, LiebR, WittchenH-U, HenquetC.Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study. Psychol Med. 2011;41(10):2121–2129.
74.
KuepperR, van OsJ, LiebR, WittchenH-U, HöflerM, HenquetC.Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ. 2011;342:d738.
75.
McGrathJ, WelhamJ, ScottJ, . Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5):440–447.
76.
ValmaggiaLR, DayFL, JonesC, . Cannabis use and transition to psychosis in people at ultra-high risk. Psychol Med. 2014;44(12):2503–2512.
77.
MiettunenJ, TörmänenS, MurrayGK, . Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry. 2008;192(6):470–471.
78.
LodhiRJ, WangY, RossolatosD, . Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain Behav. 2017;7(11):e00850.
79.
SchubartCD, Van GastelWA, BreetveltEJ, . Cannabis use at a young age is associated with psychotic experiences. Psychol Med. 2011;41(6):1301–1310.
80.
SchimmelmannBG, ConusP, CottonSM, . Cannabis use disorder and age at onset of psychosis–a study in first-episode patients. Schizophr Res. 2011;129(1):52–56.
81.
KoningsM, HenquetC, MaharajhHD, HutchinsonG, Van OsJ.Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr Scand. 2008;118(3):209–213.
82.
van GastelWA, WigmanJTW, MonshouwerK, . Cannabis use and subclinical positive psychotic experiences in early adolescence: findings from a Dutch survey. Addiction. 2012;107(2):381–387.
83.
MadraisauS, TomoichiU, OrdLM, . Early signs and symptoms of psychosis among Palauan adolescents. Early Interv Psychiatry. 2010;4(2):153–161.
84.
RingenPA, NesvågR, HelleS, . Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder. Psychol Med. 2016;46(15):3127–3136.
85.
ScottJ, MartinG, BorW, SawyerM, ClarkJ, McGrathJ.The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res. 2009;107(2–3):179–185.
86.
StefanisNC, DragovicM, PowerBD, JablenskyA, CastleD, MorganVA.Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr Bull. 2013;39(2):251–254.
87.
HidesL, LubmanDI, BuckbyJ, . The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res. 2009;112(1–3):130–135.
88.
ColinsO, VermeirenR, VreugdenhilC, SchuytenG, BroekaertE, KrabbendamA.Are psychotic experiences among detained juvenile offenders explained by trauma and substance use?Drug Alcohol Depend. 2009;100(1–2):39–46.
89.
AlibrahimO, ElawadN, MisauYA, ShaikhTM, AllamN.Drug dependence and psychotic symptoms: a retrospective study of adolescents who abuse drugs at Al-Amal Hospital in Jeddah, Saudi Arabia. J Public Health Afr. 2012;3(1):e5.
90.
StefanisNC, DelespaulP, HenquetC, . Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004;99(10):1333–1341.
91.
DolphinL, DooleyB, FitzgeraldA.Prevalence and correlates of psychotic like experiences in a nationally representative community sample of adolescents in Ireland. Schizophr Res. 2015;169(1–3):241–247.
92.
EstradaG, Fatjó-VilasM, MuñozMJ, . Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand. 2011;123(6):485–492.
93.
HarleyM, KelleherI, ClarkeM, . Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med. 2010;40(10):1627–1634.
94.
HodginsS, LarmP, WestermanJ.Individuals developing schizophrenia are hidden among adolescent substance misusers. Psychol Med. 2016;46(14):3041–3050.
95.
ManéA, BergéD, PenzolMJ, PEPs Group, . Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Res. 2017;250:38–43.
96.
BarrigónML, GurpeguiM, Ruiz-VeguillaM, . Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. J Psychiatr Res. 2010;44(7):413–420.
97.
Fonseca-PedreroE, Lucas-MolinaB, Pérez-AlbénizA, InchaustiF, Ortuño-SierraJ.Psychotic-like experiences and cannabis use in adolescents from the general population. Adicciones. 2020;32(1):41–51.
98.
HoustonJE, MurphyJ, ShevlinM, AdamsonG.Cannabis use and psychosis: re-visiting the role of childhood trauma. Psychol Med. 2011;41(11):2339–2348.
99.
RonceroC, Palma-ÁlvarezRF, BarrauV, Servicio de Psiquiatría, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Biomedicina de Salamanca (IBSAL), Universidad de Salamanca, Salamanca, España, . Early cannabis use and its relation to the development of psychiatric disorders: a review. SM. 2017;40(6):291–298.
100.
BaudinG, GodinO, LajnefM, FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Collaborators, . Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia. Schizophr Res. 2016;175(1–3):161–167.
101.
MillsR, KiselyS, AlatiR, StrathearnL, NajmanJM.Child maltreatment and cannabis use in young adulthood: a birth cohort study. Addiction. 2017;112(3):494–501.
102.
CoughlanH, CannonM.Does childhood trauma play a role in aetiology of psychosis? A review of recent evidence. BJPsych Advances. 2017;23(5):307–317.
103.
‘GurilloP, JauharS, MurrayRM, MaccabeJH.Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry. 2015;2(8):718–725.
104.
AgrawalA, LynskeyMT.Cannabis controversies: how genetics can inform the study of comorbidity. Addiction. 2014;109(3):360–370.
105.
VaessenTSJ, De JongL, SchäferAT, . The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta ± analysis. PLOS One. 2018;13(2):e0192658–22.
106.
GageSH, HickmanM, ZammitS.Association between cannabis and psychosis: Epidemiologic evidence. Biol Psychiatry. 2016;79(7):549–556.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
